Selected research
Market Outlook & Growth Opportunities
Global Animal Microbiome Market Outlook and Growth Opportunities 2026
Market perspective
The global Animal Microbiome market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Animal Microbiome is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Animal Microbiome is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Animal Microbiome is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Animal Microbiome market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Animal Microbiome market include Adisseo, Animab, AnimalBiome, Anizome, BaseClear, CanBiocin, Chr. Hansen Holding, DNA Genotek and Hill's Pet Nutrition, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Animal Microbiome market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Animal Microbiome and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Animal Microbiome revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Animal Microbiome market.
Animal Microbiome Segment by Company
Adisseo
Animab
AnimalBiome
Anizome
BaseClear
CanBiocin
Chr. Hansen Holding
DNA Genotek
Hill's Pet Nutrition
IFF
Lallemand
Lesaffre
MicroSintesis
MiDOG
Pando Nutrition
ProDigest
Tharos Ltd.
Animal Microbiome Segment by Type
Testing Service
Supplemental Product
Animal Microbiome Segment by Application
Skin Condition
Vomiting
Chronic Diarrhea
Constipation
Other
Animal Microbiome Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Animal Microbiome status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Animal Microbiome key companies, revenue, market share, and recent developments.
3. To split the Animal Microbiome breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Animal Microbiome market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Animal Microbiome significant trends, drivers, influence factors in global and regions.
6. To analyze Animal Microbiome competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Microbiome market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Microbiome and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Microbiome.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Animal Microbiome industry.
Chapter 3: Detailed analysis of Animal Microbiome company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Animal Microbiome in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Animal Microbiome in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Animal Microbiome Industry Trends
Table 2. Animal Microbiome Industry Drivers
Table 3. Animal Microbiome Industry Opportunities and Challenges
Table 4. Animal Microbiome Industry Restraints
Table 5. Global Animal Microbiome Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Animal Microbiome Revenue Share by Company (2021-2026)
Table 7. Global Animal Microbiome Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Animal Microbiome Key Company Manufacturing Base & Headquarters
Table 9. Global Animal Microbiome Company, Product Type & Application
Table 10. Global Animal Microbiome Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Animal Microbiome by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Testing Service
Table 15. Significant Companies of Supplemental Product
Table 16. Global Animal Microbiome Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 17. Global Animal Microbiome Sales Value by Type (2021-2026) & (US$ Million)
Table 18. Global Animal Microbiome Sales Value by Type (2027-2032) & (US$ Million)
Table 19. Global Animal Microbiome Sales Value Share by Type (2021-2026)
Table 20. Global Animal Microbiome Sales Value Share by Type (2027-2032)
Table 21. Significant Companies of Skin Condition
Table 22. Significant Companies of Vomiting
Table 23. Significant Companies of Chronic Diarrhea
Table 24. Significant Companies of Constipation
Table 25. Significant Companies of Other
Table 26. Global Animal Microbiome Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 27. Global Animal Microbiome Sales Value by Application (2021-2026) & (US$ Million)
Table 28. Global Animal Microbiome Sales Value by Application (2027-2032) & (US$ Million)
Table 29. Global Animal Microbiome Sales Value Share by Application (2021-2026)
Table 30. Global Animal Microbiome Sales Value Share by Application (2027-2032)
Table 31. Global Animal Microbiome Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 32. Global Animal Microbiome Sales Value by Region (2021-2026) & (US$ Million)
Table 33. Global Animal Microbiome Sales Value Share by Region (2021-2026)
Table 34. Global Animal Microbiome Sales Value by Region (2027-2032) & (US$ Million)
Table 35. Global Animal Microbiome Sales Value Share by Region (2027-2032)
Table 36. Global Animal Microbiome Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Global Animal Microbiome Sales Value by Country (2021-2026) & (US$ Million)
Table 38. Global Animal Microbiome Sales Value Market Share by Country (2021-2026)
Table 39. Global Animal Microbiome Sales Value by Country (2027-2032) & (US$ Million)
Table 40. Global Animal Microbiome Sales Value Market Share by Country (2027-2032)
Table 41. Adisseo Company Information
Table 42. Adisseo Business Overview
Table 43. Adisseo Animal Microbiome Revenue (US$ Million) and Gross Margin (2021-2026)
Table 44. Adisseo Animal Microbiome Product Portfolio
Table 45. Adisseo Recent Development
Table 46. Animab Company Information
Table 47. Animab Business Overview
Table 48. Animab Animal Microbiome Revenue (US$ Million) and Gross Margin (2021-2026)
Table 49. Animab Animal Microbiome Product Portfolio
Table 50. Animab Recent Development
Table 51. AnimalBiome Company Information
Table 52. AnimalBiome Business Overview
Table 53. AnimalBiome Animal Microbiome Revenue (US$ Million) and Gross Margin (2021-2026)
Table 54. AnimalBiome Animal Microbiome Product Portfolio
Table 55. AnimalBiome Recent Development
Table 56. Anizome Company Information
Table 57. Anizome Business Overview
Table 58. Anizome Animal Microbiome Revenue (US$ Million) and Gross Margin (2021-2026)
Table 59. Anizome Animal Microbiome Product Portfolio
Table 60. Anizome Recent Development
Table 61. BaseClear Company Information
Table 62. BaseClear Business Overview
Table 63. BaseClear Animal Microbiome Revenue (US$ Million) and Gross Margin (2021-2026)
Table 64. BaseClear Animal Microbiome Product Portfolio
Table 65. BaseClear Recent Development
Table 66. CanBiocin Company Information
Table 67. CanBiocin Business Overview
Table 68. CanBiocin Animal Microbiome Revenue (US$ Million) and Gross Margin (2021-2026)
Table 69. CanBiocin Animal Microbiome Product Portfolio
Table 70. CanBiocin Recent Development
Table 71. Chr. Hansen Holding Company Information
Table 72. Chr. Hansen Holding Business Overview
Table 73. Chr. Hansen Holding Animal Microbiome Revenue (US$ Million) and Gross Margin (2021-2026)
Table 74. Chr. Hansen Holding Animal Microbiome Product Portfolio
Table 75. Chr. Hansen Holding Recent Development
Table 76. DNA Genotek Company Information
Table 77. DNA Genotek Business Overview
Table 78. DNA Genotek Animal Microbiome Revenue (US$ Million) and Gross Margin (2021-2026)
Table 79. DNA Genotek Animal Microbiome Product Portfolio
Table 80. DNA Genotek Recent Development
Table 81. Hill's Pet Nutrition Company Information
Table 82. Hill's Pet Nutrition Business Overview
Table 83. Hill's Pet Nutrition Animal Microbiome Revenue (US$ Million) and Gross Margin (2021-2026)
Table 84. Hill's Pet Nutrition Animal Microbiome Product Portfolio
Table 85. Hill's Pet Nutrition Recent Development
Table 86. IFF Company Information
Table 87. IFF Business Overview
Table 88. IFF Animal Microbiome Revenue (US$ Million) and Gross Margin (2021-2026)
Table 89. IFF Animal Microbiome Product Portfolio
Table 90. IFF Recent Development
Table 91. Lallemand Company Information
Table 92. Lallemand Business Overview
Table 93. Lallemand Animal Microbiome Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Lallemand Animal Microbiome Product Portfolio
Table 95. Lallemand Recent Development
Table 96. Lesaffre Company Information
Table 97. Lesaffre Business Overview
Table 98. Lesaffre Animal Microbiome Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Lesaffre Animal Microbiome Product Portfolio
Table 100. Lesaffre Recent Development
Table 101. MicroSintesis Company Information
Table 102. MicroSintesis Business Overview
Table 103. MicroSintesis Animal Microbiome Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. MicroSintesis Animal Microbiome Product Portfolio
Table 105. MicroSintesis Recent Development
Table 106. MiDOG Company Information
Table 107. MiDOG Business Overview
Table 108. MiDOG Animal Microbiome Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. MiDOG Animal Microbiome Product Portfolio
Table 110. MiDOG Recent Development
Table 111. Pando Nutrition Company Information
Table 112. Pando Nutrition Business Overview
Table 113. Pando Nutrition Animal Microbiome Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Pando Nutrition Animal Microbiome Product Portfolio
Table 115. Pando Nutrition Recent Development
Table 116. ProDigest Company Information
Table 117. ProDigest Business Overview
Table 118. ProDigest Animal Microbiome Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. ProDigest Animal Microbiome Product Portfolio
Table 120. ProDigest Recent Development
Table 121. Tharos Ltd. Company Information
Table 122. Tharos Ltd. Business Overview
Table 123. Tharos Ltd. Animal Microbiome Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Tharos Ltd. Animal Microbiome Product Portfolio
Table 125. Tharos Ltd. Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Authors List of This Report
Table 128. Secondary Sources
Table 129. Primary Sources
List of Figures
Figure 1. Animal Microbiome Product Image
Figure 2. Global Animal Microbiome Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Animal Microbiome Market Size (2021-2032) & (US$ Million)
Figure 4. Global Animal Microbiome Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Testing Service Image
Figure 8. Supplemental Product Image
Figure 9. Global Animal Microbiome Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 10. Global Animal Microbiome Sales Value Share 2021 VS 2025 VS 2032
Figure 11. Global Animal Microbiome Sales Value Share by Type (2021-2032)
Figure 12. Skin Condition Image
Figure 13. Vomiting Image
Figure 14. Chronic Diarrhea Image
Figure 15. Constipation Image
Figure 16. Other Image
Figure 17. Global Animal Microbiome Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 18. Global Animal Microbiome Sales Value Share 2021 VS 2025 VS 2032
Figure 19. Global Animal Microbiome Sales Value Share by Application (2021-2032)
Figure 20. Global Animal Microbiome Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 21. Global Animal Microbiome Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 22. North America Animal Microbiome Sales Value (2021-2032) & (US$ Million)
Figure 23. North America Animal Microbiome Sales Value Share by Country (%), 2025 VS 2032
Figure 24. Europe Animal Microbiome Sales Value (2021-2032) & (US$ Million)
Figure 25. Europe Animal Microbiome Sales Value Share by Country (%), 2025 VS 2032
Figure 26. Asia-Pacific Animal Microbiome Sales Value (2021-2032) & (US$ Million)
Figure 27. Asia-Pacific Animal Microbiome Sales Value Share by Country (%), 2025 VS 2032
Figure 28. South America Animal Microbiome Sales Value (2021-2032) & (US$ Million)
Figure 29. South America Animal Microbiome Sales Value Share by Country (%), 2025 VS 2032
Figure 30. Middle East & Africa Animal Microbiome Sales Value (2021-2032) & (US$ Million)
Figure 31. Middle East & Africa Animal Microbiome Sales Value Share by Country (%), 2025 VS 2032
Figure 32. USA Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 33. USA Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 34. USA Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 35. Canada Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 36. Canada Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 37. Canada Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 38. Mexico Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 39. Mexico Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 40. Mexico Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 41. Germany Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 42. Germany Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 43. Germany Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 44. France Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 45. France Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 46. France Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 47. U.K. Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 48. U.K. Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 49. U.K. Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 50. Italy Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 51. Italy Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 52. Italy Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 53. Spain Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 54. Spain Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 55. Spain Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 56. Russia Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 57. Russia Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 58. Russia Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 59. Netherlands Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 60. Netherlands Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 61. Netherlands Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 62. Nordic Countries Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 63. Nordic Countries Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 64. Nordic Countries Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 65. China Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 66. China Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 67. China Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 68. Japan Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 69. Japan Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 70. Japan Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 71. South Korea Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 72. South Korea Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 73. South Korea Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 74. India Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 75. India Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 76. India Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 77. Australia Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 78. Australia Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 79. Australia Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 80. Southeast Asia Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 81. Southeast Asia Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 82. Southeast Asia Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 83. Brazil Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 84. Brazil Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 85. Brazil Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 86. Argentina Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 87. Argentina Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 88. Argentina Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 89. Chile Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 90. Chile Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 91. Chile Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 92. Colombia Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 93. Colombia Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 94. Colombia Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 95. Peru Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 96. Peru Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 97. Peru Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 98. Saudi Arabia Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 99. Saudi Arabia Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 100. Saudi Arabia Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 101. Israel Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 102. Israel Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 103. Israel Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 104. UAE Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 105. UAE Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 106. UAE Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 107. Turkey Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 108. Turkey Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 109. Turkey Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 110. Iran Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 111. Iran Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 112. Iran Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 113. Egypt Animal Microbiome Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 114. Egypt Animal Microbiome Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 115. Egypt Animal Microbiome Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 116. Years Considered
Figure 117. Research Process
Figure 118. Key Executives Interviewed
Scope & coverage.
Types
- Testing Service
- Supplemental Product
Applications
- Skin Condition
- Vomiting
- Chronic Diarrhea
- Constipation
- Other
Companies covered
- Adisseo
- Animab
- AnimalBiome
- Anizome
- BaseClear
- CanBiocin
- Chr. Hansen Holding
- DNA Genotek
- Hill's Pet Nutrition
- IFF
- Lallemand
- Lesaffre
- MicroSintesis
- MiDOG
- Pando Nutrition
- ProDigest
- Tharos Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Animal Microbiome Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Animal Microbiome Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Animal Microbiome Market Dynamics
- 2.1 Animal Microbiome Industry Trends
- 2.2 Animal Microbiome Industry Drivers
- 2.3 Animal Microbiome Industry Opportunities and Challenges
- 2.4 Animal Microbiome Industry Restraints
3 Animal Microbiome Market by Company
- 3.1 Global Animal Microbiome Company Revenue Ranking in 2025
- 3.2 Global Animal Microbiome Revenue by Company (2021-2026)
- 3.3 Global Animal Microbiome Company Ranking (2024-2026)
- 3.4 Global Animal Microbiome Company Manufacturing Base and Headquarters
- 3.5 Global Animal Microbiome Company Product Type and Application
- 3.6 Global Animal Microbiome Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Animal Microbiome Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Animal Microbiome Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Animal Microbiome Market by Type
- 4.1 Animal Microbiome Type Introduction
- 4.1.1 Testing Service
- 4.1.2 Supplemental Product
- 4.2 Global Animal Microbiome Sales Value by Type
- 4.2.1 Global Animal Microbiome Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Animal Microbiome Sales Value by Type (2021-2032)
- 4.2.3 Global Animal Microbiome Sales Value Share by Type (2021-2032)
5 Animal Microbiome Market by Application
- 5.1 Animal Microbiome Application Introduction
- 5.1.1 Skin Condition
- 5.1.2 Vomiting
- 5.1.3 Chronic Diarrhea
- 5.1.4 Constipation
- 5.1.5 Other
- 5.2 Global Animal Microbiome Sales Value by Application
- 5.2.1 Global Animal Microbiome Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Animal Microbiome Sales Value by Application (2021-2032)
- 5.2.3 Global Animal Microbiome Sales Value Share by Application (2021-2032)
6 Animal Microbiome Regional Value Analysis
- 6.1 Global Animal Microbiome Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Animal Microbiome Sales Value by Region (2021-2032)
- 6.2.1 Global Animal Microbiome Sales Value by Region: 2021-2026
- 6.2.2 Global Animal Microbiome Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Animal Microbiome Sales Value (2021-2032)
- 6.3.2 North America Animal Microbiome Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Animal Microbiome Sales Value (2021-2032)
- 6.4.2 Europe Animal Microbiome Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Animal Microbiome Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Animal Microbiome Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Animal Microbiome Sales Value (2021-2032)
- 6.6.2 South America Animal Microbiome Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Animal Microbiome Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Animal Microbiome Sales Value Share by Country, 2025 VS 2032
7 Animal Microbiome Country-level Value Analysis
- 7.1 Global Animal Microbiome Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Animal Microbiome Sales Value by Country (2021-2032)
- 7.2.1 Global Animal Microbiome Sales Value by Country (2021-2026)
- 7.2.2 Global Animal Microbiome Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.7.2 France Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.14.2 China Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.17.2 India Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Animal Microbiome Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Animal Microbiome Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Animal Microbiome Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Animal Microbiome Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Adisseo
- 8.1.1 Adisseo Company Information
- 8.1.2 Adisseo Business Overview
- 8.1.3 Adisseo Animal Microbiome Revenue and Gross Margin (2021-2026)
- 8.1.4 Adisseo Animal Microbiome Product Portfolio
- 8.1.5 Adisseo Recent Developments
- 8.2 Animab
- 8.2.1 Animab Company Information
- 8.2.2 Animab Business Overview
- 8.2.3 Animab Animal Microbiome Revenue and Gross Margin (2021-2026)
- 8.2.4 Animab Animal Microbiome Product Portfolio
- 8.2.5 Animab Recent Developments
- 8.3 AnimalBiome
- 8.3.1 AnimalBiome Company Information
- 8.3.2 AnimalBiome Business Overview
- 8.3.3 AnimalBiome Animal Microbiome Revenue and Gross Margin (2021-2026)
- 8.3.4 AnimalBiome Animal Microbiome Product Portfolio
- 8.3.5 AnimalBiome Recent Developments
- 8.4 Anizome
- 8.4.1 Anizome Company Information
- 8.4.2 Anizome Business Overview
- 8.4.3 Anizome Animal Microbiome Revenue and Gross Margin (2021-2026)
- 8.4.4 Anizome Animal Microbiome Product Portfolio
- 8.4.5 Anizome Recent Developments
- 8.5 BaseClear
- 8.5.1 BaseClear Company Information
- 8.5.2 BaseClear Business Overview
- 8.5.3 BaseClear Animal Microbiome Revenue and Gross Margin (2021-2026)
- 8.5.4 BaseClear Animal Microbiome Product Portfolio
- 8.5.5 BaseClear Recent Developments
- 8.6 CanBiocin
- 8.6.1 CanBiocin Company Information
- 8.6.2 CanBiocin Business Overview
- 8.6.3 CanBiocin Animal Microbiome Revenue and Gross Margin (2021-2026)
- 8.6.4 CanBiocin Animal Microbiome Product Portfolio
- 8.6.5 CanBiocin Recent Developments
- 8.7 Chr. Hansen Holding
- 8.7.1 Chr. Hansen Holding Company Information
- 8.7.2 Chr. Hansen Holding Business Overview
- 8.7.3 Chr. Hansen Holding Animal Microbiome Revenue and Gross Margin (2021-2026)
- 8.7.4 Chr. Hansen Holding Animal Microbiome Product Portfolio
- 8.7.5 Chr. Hansen Holding Recent Developments
- 8.8 DNA Genotek
- 8.8.1 DNA Genotek Company Information
- 8.8.2 DNA Genotek Business Overview
- 8.8.3 DNA Genotek Animal Microbiome Revenue and Gross Margin (2021-2026)
- 8.8.4 DNA Genotek Animal Microbiome Product Portfolio
- 8.8.5 DNA Genotek Recent Developments
- 8.9 Hill's Pet Nutrition
- 8.9.1 Hill's Pet Nutrition Company Information
- 8.9.2 Hill's Pet Nutrition Business Overview
- 8.9.3 Hill's Pet Nutrition Animal Microbiome Revenue and Gross Margin (2021-2026)
- 8.9.4 Hill's Pet Nutrition Animal Microbiome Product Portfolio
- 8.9.5 Hill's Pet Nutrition Recent Developments
- 8.10 IFF
- 8.10.1 IFF Company Information
- 8.10.2 IFF Business Overview
- 8.10.3 IFF Animal Microbiome Revenue and Gross Margin (2021-2026)
- 8.10.4 IFF Animal Microbiome Product Portfolio
- 8.10.5 IFF Recent Developments
- 8.11 Lallemand
- 8.11.1 Lallemand Company Information
- 8.11.2 Lallemand Business Overview
- 8.11.3 Lallemand Animal Microbiome Revenue and Gross Margin (2021-2026)
- 8.11.4 Lallemand Animal Microbiome Product Portfolio
- 8.11.5 Lallemand Recent Developments
- 8.12 Lesaffre
- 8.12.1 Lesaffre Company Information
- 8.12.2 Lesaffre Business Overview
- 8.12.3 Lesaffre Animal Microbiome Revenue and Gross Margin (2021-2026)
- 8.12.4 Lesaffre Animal Microbiome Product Portfolio
- 8.12.5 Lesaffre Recent Developments
- 8.13 MicroSintesis
- 8.13.1 MicroSintesis Company Information
- 8.13.2 MicroSintesis Business Overview
- 8.13.3 MicroSintesis Animal Microbiome Revenue and Gross Margin (2021-2026)
- 8.13.4 MicroSintesis Animal Microbiome Product Portfolio
- 8.13.5 MicroSintesis Recent Developments
- 8.14 MiDOG
- 8.14.1 MiDOG Company Information
- 8.14.2 MiDOG Business Overview
- 8.14.3 MiDOG Animal Microbiome Revenue and Gross Margin (2021-2026)
- 8.14.4 MiDOG Animal Microbiome Product Portfolio
- 8.14.5 MiDOG Recent Developments
- 8.15 Pando Nutrition
- 8.15.1 Pando Nutrition Company Information
- 8.15.2 Pando Nutrition Business Overview
- 8.15.3 Pando Nutrition Animal Microbiome Revenue and Gross Margin (2021-2026)
- 8.15.4 Pando Nutrition Animal Microbiome Product Portfolio
- 8.15.5 Pando Nutrition Recent Developments
- 8.16 ProDigest
- 8.16.1 ProDigest Company Information
- 8.16.2 ProDigest Business Overview
- 8.16.3 ProDigest Animal Microbiome Revenue and Gross Margin (2021-2026)
- 8.16.4 ProDigest Animal Microbiome Product Portfolio
- 8.16.5 ProDigest Recent Developments
- 8.17 Tharos Ltd.
- 8.17.1 Tharos Ltd. Company Information
- 8.17.2 Tharos Ltd. Business Overview
- 8.17.3 Tharos Ltd. Animal Microbiome Revenue and Gross Margin (2021-2026)
- 8.17.4 Tharos Ltd. Animal Microbiome Product Portfolio
- 8.17.5 Tharos Ltd. Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst